Hypolipoproteinemia Overview

Save information for later
Sign Up

Learn About Hypolipoproteinemia

What is the definition of Hypolipoproteinemia?
Hypolipoproteinemia refers to unusually low levels of fats (lipids) in the blood. Low lipid levels may be caused by rare genetic conditions, or be a sign of another disorder such as overactive thyroid, anemia, undernutrition, cancer, chronic infection, or impaired absorption of foods from the digestive tract. Associated genetic disorders includes abetalipoproteinemia, familial hypobetalipoproteinemia, and chylomicron retention disease. Signs and symptoms in the the genetic or familial form of Hypolipoproteinemia vary. In some forms, although the low density lipoprotein (LDL) cholesterol levels are very low, this syndrome may not cause any symptoms. Other forms result in absent or near absent LDL levels and can cause symptoms in infancy and early childhood.
What are the alternative names for Hypolipoproteinemia?
  • Hypolipoproteinemia
Who are the top Hypolipoproteinemia Local Doctors?
Elite in Hypolipoproteinemia
Dr. Daniel J. Rader
Cardiology | Medical Genetics
Elite in Hypolipoproteinemia
Dr. Daniel J. Rader
Cardiology | Medical Genetics

Penn Heart And Vascular Center

3400 Civic Center Boulevard, East Pavilion, 2nd Floor, 
Philadelphia, PA 
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Rader is a Cardiologist and a Medical Genetics provider in Philadelphia, Pennsylvania. Dr. Rader is rated as an Elite provider by MediFind in the treatment of Hypolipoproteinemia. His top areas of expertise are Homozygous Familial Hypercholesterolemia (HoFH), High Cholesterol, Coronary Heart Disease, Atherosclerosis, and Heart Transplant. Dr. Rader is currently accepting new patients.

Elite in Hypolipoproteinemia
Patrizia Tarugi
Elite in Hypolipoproteinemia
Patrizia Tarugi
Reggio Nell'emilia, IT 

Patrizia Tarugi practices in Reggio Nell'emilia, Italy. Ms. Tarugi is rated as an Elite expert by MediFind in the treatment of Hypolipoproteinemia. Her top areas of expertise are Familial Hypobetalipoproteinemia, Hypolipoproteinemia, Abetalipoproteinemia, and Familial Hypercholesterolemia.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Hypolipoproteinemia
Laura Calabresi
Elite in Hypolipoproteinemia
Laura Calabresi
Milan, IT 

Laura Calabresi practices in Milan, Italy. Ms. Calabresi is rated as an Elite expert by MediFind in the treatment of Hypolipoproteinemia. Her top areas of expertise are Fish-Eye Disease, Hypolipoproteinemia, Apo A-I Deficiency, and Atherosclerosis.

View All Doctors
What are the latest Hypolipoproteinemia Clinical Trials?
LCAT Deficiency Disorders: Natural History and Identification of Biomarkers
LCAT Deficiency Disorders: Natural History and Identification of Biomarkers
Enrollment Status: Recruiting
Publish Date: April 30, 2025
Intervention Type: Other

Summary: The purpose of the LCAT (Lecithin cholesterol acyl transferase) Natural History Study (LCAT NHS) is to help identify people with a mutation in a gene called LCAT, collect and store information about their medical history and disease course, and to assess for associations and follow changes in clinical features and biomarkers of disease. This information will help health care providers better under...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Foundation Fighting Blindness My Retina Tracker Registry
Foundation Fighting Blindness My Retina Tracker Registry
Enrollment Status: Recruiting
Publish Date: March 27, 2025

Summary: The My Retina Tracker® Registry is sponsored by the Foundation Fighting Blindness and is for people affected by one of the rare inherited retinal degenerative diseases studied by the Foundation. It is a patient-initiated registry accessible via a secure on-line portal at www.MyRetinaTracker.org. Affected individuals who register are guided to create a profile that captures their perspective on the...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center